While existing studies have confirmed that neutrophils and albumin are associated with functional outcomes in AIS patients undergoing reperfusion therapy (32, 33), there is insufficient evidence to suggest that NPAR predicts outcomes in AIS patients receiving intravenous thrombolysis. The gene discussed is ALB; the disease is androgen insensitivity syndrome.